Clinical trials recruiting for Cervical cancer
71
Recruiting trials
34
US states with sites
26
Countries
14%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 21 |
| Texas | 20 |
| Florida | 13 |
| Illinois | 10 |
| New York | 10 |
| Tennessee | 10 |
| Colorado | 8 |
| Massachusetts | 7 |
| Virginia | 7 |
| Michigan | 6 |
| North Carolina | 6 |
| New Jersey | 5 |
Top cities
Houston, Texas 15Nashville, Tennessee 10Los Angeles, California 9Chicago, Illinois 8New York, New York 8Boston, Massachusetts 7Duarte, California 7Fairfax, Virginia 6San Antonio, Texas 6Miami, Florida 5
Self-screener
Recruiting trials
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- A Beta-only IL-2 ImmunoTherapY Study
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
- A Multicenter Cancer Biospecimen Collection Study
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
- A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- A Study of MGC026 in Participants With Advanced Solid Tumors
- A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- A Study of NX-1607 in Adults With Advanced Malignancies
- A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- A Study of VET3-TGI in Patients With Solid Tumors
- A Study of YL202 in Patients With Advanced Solid Tumors
- A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
- ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
- CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
- Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
- Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
- DESTINY-PANTUMOUR04
- Deciphering Mechanisms Underlying Cancer Immunogenicity
- Detecting HPV DNA in Anal and Cervical Cancers
- Distance-Based Exercise to Preserve Function and Prevent Disability
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Early Ageing During Therapy in AYA Cancer Patients
- Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
- Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
- Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
- Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
- HRYZ-T101 Injection for HPV18 Positive Solid Tumor
- Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)
- Improving Care for Rural Patients With Solid Tumors
- Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
- KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
- MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
- NYSCF Scientific Discovery Biobank
- Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy
- Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
- SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
- Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
- Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
- Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
- Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Trop2-targeted immunoPET Imaging of Solid Tumors
- Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
- a Single-arm, Single-center, Open Clinical Study
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Related conditions
Trials recruiting for Cervical cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Breast cancer 2239Colorectal cancer 1359Ovarian cancer 118Endometrial cancer 68Pancreatic cancer 870Prostate cancer 1234Non-small cell lung cancer 507Gastric cancer 91Melanoma 487
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cervical cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.